462-04-003 ISMRM Abstract

DTI FA/MD Quantify Cyr61–Wnt/β-Catenin Remodeling in Sarcopenic Rat Muscle

Primary: Preclinical Animal & in vitro MR - Biology, Models, Methods

Secondary: Musculoskeletal - Functional/Dynamic

462-04-003 · Body, Cardiovascular, and Musculoskeletal Systems in Small Animals · Tuesday, 12 May, 2:35 PM–3:30 PM · Digital Posters Row C

Keywords: Biomarkers Diffusion-weighted MRI Fibrosis Sarcopenia Preclinical Animal Models

Accepted

xiaoling kui ¹, Lisha Nie², Bo He¹

¹Medical imaging department, Medical imaging department，First Affiliated Hospital of Kunming Medical University, Kunming, China

²GE Healthcare, MR Research China, Beijing, China

Presenting Author: xiaoling kui

Synopsis

Motivation:

Goals:

Approach:

Results:

Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

References

1. Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, Abellan van Kan G, Andrieu S, Bauer J, Breuille D et al: Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. Journal of the American Medical Directors Association 2011, 12(4):249-256. doi: 10.1016/j.jamda.2011.01.003. [doi]

2. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA et al: Sarcopenia: revised European consensus on definition and diagnosis. Age and ageing 2019, 48(4):601. doi: 10.1093/ageing/afz046. [doi]

3. Jun JI, Lau LF: Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nature reviews Drug discovery 2011, 10(12):945-963. doi: 10.1038/nrd3599. [doi]

4. Kireeva ML, Mo FE, Yang GP, Lau LF: Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion. Molecular and cellular biology 1996, 16(4):1326-1334. doi: 10.1128/MCB.16.4.1326. [doi]

5. Fouré A, Ogier AC, Le Troter A, Vilmen C, Feiweier T, Guye M, Gondin J, Besson P, Bendahan D: Diffusion Properties and 3D Architecture of Human Lower Leg Muscles Assessed with Ultra-High-Field-Strength Diffusion-Tensor MR Imaging and Tractography: Reproducibility and Sensitivity to Sex Difference and Intramuscular Variability. Radiology 2018, 287(2):592-607. doi: 10.1148/radiol.2017171330. [doi]

6. Hunt LC, Graca FA, Pagala V, Wang YD, Li Y, Yuan ZF, Fan Y, Labelle M, Peng J, Demontis F: Integrated genomic and proteomic analyses identify stimulus-dependent molecular changes associated with distinct modes of skeletal muscle atrophy. Cell reports 2021, 37(6):109971. doi: 10.1016/j.celrep.2021.109971. [doi]

7. von Maltzahn J, Chang NC, Bentzinger CF, Rudnicki MA: Wnt signaling in myogenesis. Trends in cell biology 2012, 22(11):602-609. doi: 10.1016/j.tcb.2012.07.008. [doi]

8. Brack AS, Conboy MJ, Roy S, Lee M, Kuo CJ, Keller C, Rando TA: Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science (New York, NY) 2007, 317(5839):807-810. doi: 10.1126/science.1144090. [doi]

9. Chaqour B, Goppelt-Struebe M: Mechanical regulation of the Cyr61/CCN1 and CTGF/CCN2 proteins. The FEBS journal 2006, 273(16):3639-3649. doi: 10.1111/j.1742-4658.2006.05360.x. [doi]

10. Oudeman J, Nederveen AJ, Strijkers GJ, Maas M, Luijten PR, Froeling M: Techniques and applications of skeletal muscle diffusion tensor imaging: A review. Journal of magnetic resonance imaging : JMRI 2016, 43(4):773-788. doi: 10.1002/jmri.25016. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/462-04-003